MIGDAL HA’EMEQ, Israel, Dec. 9, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-functional lipid ingredients, announced today the acceptance for future publication of its clinical study results evaluating the safety and effectiveness of Vayacog® usage in non-demented elderly.
Help employers find you! Check out all the jobs and post your resume.
